AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 59,100
-5,500 (-8.51%)
At close: Feb 6, 2026
AprilBio Company Description
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies.
It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases.
The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.
AprilBio Co.,Ltd.
| Country | South Korea |
| Founded | 2013 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Sang-Hoon Cha |
Contact Details
Address: Room 602, Building B Chuncheon-si, 24341 South Korea | |
| Phone | 82 2 6956 8383 |
| Website | aprilbio.com |
Stock Details
| Ticker Symbol | 397030 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Sang-Hoon Cha | Chief Executive Officer |
| Jin-Taek Kim | Chief Financial Officer |